Renamed Coave Therapeutics Raises $39m To Fund Its Next-Gen Gene Therapies
Conjugation Tech Could Improve Gene Delivery
The company aims to overcome drawbacks of existing gene therapy platforms, starting in ocular and CNS diseases.
You may also be interested in...
Appili brings in AiPharma to help with US/Canadian development of Fujifilm’s potential COVID-19 preventative/therapeutic. Other recent tie-ups include CinFina/Janssen, Bone/Impant, Bayer/Gubra, Novartis/Theragnostics, Grifols/Biotest and more.
French biotech GenSight will prioritize its optogenetic GS030 treatment after the combination showed breakthrough results in a form of blindness, its CEO tells Scrip.
Bepirovirsen made the hepatitis B virus undetectable in nearly 30% of patients in a Phase II study – but it remains to be seen whether this response be sustained once treatment with the novel antisense product ends.